Brief: Repare Therapeutics Announces Achievement Of $40 Million Roche Clinical Milestone Payment

Repare Therapeutics

25/01/2024 13:09

Jan 25 (Reuters) - Repare Therapeutics Inc  RPTX.O :
    * REPARE THERAPEUTICS ANNOUNCES ACHIEVEMENT OF $40 MILLION
ROCHE
CLINICAL MILESTONE PAYMENT
    * REPARE THERAPEUTICS INC - REPARE IS ELIGIBLE TO RECEIVE UP
TO
$1.2 BILLION IN POTENTIAL MILESTONES, PLUS ROYALTIES ON GLOBAL
NET PRODUCT SALES
    * REPARE THERAPEUTICS- MILESTONE PAYMENT TRIGGERED BY DOSING
OF
1ST PATIENT IN CAMONSERTIB-BASED ARM IN ROCHE'S PHASE 2 TAPISTRY
PLATFORM CLINICAL TRIAL
    * REPARE THERAPEUTICS INC - COLLABORATION ALSO PROVIDES
REPARE
WITH ABILITY TO OPT-IN TO A 50/50 U.S. CO-DEVELOPMENT AND PROFIT
SHARE ARRANGEMENT

Source text for Eikon:  ID:nBw5Z1z0Ta 
Further company coverage:  RPTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))